nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—STK10—renal vein—abdominal aortic aneurysm	0.0472	0.11	CbGeAlD
Crizotinib—STK10—renal artery—abdominal aortic aneurysm	0.0317	0.0741	CbGeAlD
Crizotinib—RPS6KB1—leg—abdominal aortic aneurysm	0.0137	0.0319	CbGeAlD
Crizotinib—INSRR—kidney—abdominal aortic aneurysm	0.0135	0.0315	CbGeAlD
Crizotinib—RPS6KB1—hindlimb—abdominal aortic aneurysm	0.0122	0.0285	CbGeAlD
Crizotinib—LYN—blood plasma—abdominal aortic aneurysm	0.00813	0.019	CbGeAlD
Crizotinib—NEK9—connective tissue—abdominal aortic aneurysm	0.00702	0.0164	CbGeAlD
Crizotinib—FLT3—blood plasma—abdominal aortic aneurysm	0.00695	0.0162	CbGeAlD
Crizotinib—TEK—artery—abdominal aortic aneurysm	0.00677	0.0158	CbGeAlD
Crizotinib—PTK2B—blood plasma—abdominal aortic aneurysm	0.00633	0.0148	CbGeAlD
Crizotinib—SIK2—connective tissue—abdominal aortic aneurysm	0.00631	0.0147	CbGeAlD
Crizotinib—SRC—artery—abdominal aortic aneurysm	0.00601	0.014	CbGeAlD
Crizotinib—NEK9—kidney—abdominal aortic aneurysm	0.00598	0.0139	CbGeAlD
Crizotinib—MAP3K2—blood plasma—abdominal aortic aneurysm	0.00595	0.0139	CbGeAlD
Crizotinib—PTK2—blood plasma—abdominal aortic aneurysm	0.00583	0.0136	CbGeAlD
Crizotinib—MAPK7—connective tissue—abdominal aortic aneurysm	0.00568	0.0133	CbGeAlD
Crizotinib—PRKD1—kidney—abdominal aortic aneurysm	0.00545	0.0127	CbGeAlD
Crizotinib—MET—connective tissue—abdominal aortic aneurysm	0.00532	0.0124	CbGeAlD
Crizotinib—JAK2—blood plasma—abdominal aortic aneurysm	0.00527	0.0123	CbGeAlD
Crizotinib—PRKD3—kidney—abdominal aortic aneurysm	0.00524	0.0122	CbGeAlD
Crizotinib—CDK7—connective tissue—abdominal aortic aneurysm	0.00515	0.012	CbGeAlD
Crizotinib—JAK3—connective tissue—abdominal aortic aneurysm	0.00469	0.011	CbGeAlD
Crizotinib—STK10—blood plasma—abdominal aortic aneurysm	0.00465	0.0108	CbGeAlD
Crizotinib—TAOK3—blood plasma—abdominal aortic aneurysm	0.00463	0.0108	CbGeAlD
Crizotinib—STK4—connective tissue—abdominal aortic aneurysm	0.0046	0.0107	CbGeAlD
Crizotinib—MET—kidney—abdominal aortic aneurysm	0.00453	0.0106	CbGeAlD
Crizotinib—SRC—blood plasma—abdominal aortic aneurysm	0.00451	0.0105	CbGeAlD
Crizotinib—ALK—connective tissue—abdominal aortic aneurysm	0.00435	0.0102	CbGeAlD
Crizotinib—TYRO3—connective tissue—abdominal aortic aneurysm	0.00435	0.0102	CbGeAlD
Crizotinib—LYN—connective tissue—abdominal aortic aneurysm	0.00433	0.0101	CbGeAlD
Crizotinib—ACVR1B—kidney—abdominal aortic aneurysm	0.00419	0.00977	CbGeAlD
Crizotinib—IGF1R—connective tissue—abdominal aortic aneurysm	0.00418	0.00976	CbGeAlD
Crizotinib—CSF1R—blood plasma—abdominal aortic aneurysm	0.00405	0.00945	CbGeAlD
Crizotinib—TESK1—connective tissue—abdominal aortic aneurysm	0.00393	0.00918	CbGeAlD
Crizotinib—ACVR1—connective tissue—abdominal aortic aneurysm	0.0037	0.00864	CbGeAlD
Crizotinib—FLT3—connective tissue—abdominal aortic aneurysm	0.0037	0.00864	CbGeAlD
Crizotinib—IGF1R—kidney—abdominal aortic aneurysm	0.00356	0.00831	CbGeAlD
Crizotinib—BMP2K—connective tissue—abdominal aortic aneurysm	0.00349	0.00815	CbGeAlD
Crizotinib—AURKA—kidney—abdominal aortic aneurysm	0.00337	0.00788	CbGeAlD
Crizotinib—PTK2B—connective tissue—abdominal aortic aneurysm	0.00337	0.00787	CbGeAlD
Crizotinib—RIPK2—connective tissue—abdominal aortic aneurysm	0.00334	0.0078	CbGeAlD
Crizotinib—MAP3K2—connective tissue—abdominal aortic aneurysm	0.00317	0.0074	CbGeAlD
Crizotinib—ACVR1—kidney—abdominal aortic aneurysm	0.00315	0.00735	CbGeAlD
Crizotinib—PTK2—connective tissue—abdominal aortic aneurysm	0.0031	0.00724	CbGeAlD
Crizotinib—DCLK1—spinal cord—abdominal aortic aneurysm	0.00309	0.00721	CbGeAlD
Crizotinib—TYK2—connective tissue—abdominal aortic aneurysm	0.00308	0.0072	CbGeAlD
Crizotinib—RPS6KB1—connective tissue—abdominal aortic aneurysm	0.00299	0.00697	CbGeAlD
Crizotinib—AXL—connective tissue—abdominal aortic aneurysm	0.00296	0.0069	CbGeAlD
Crizotinib—TYRO3—spinal cord—abdominal aortic aneurysm	0.00288	0.00673	CbGeAlD
Crizotinib—FER—spinal cord—abdominal aortic aneurysm	0.00288	0.00673	CbGeAlD
Crizotinib—EPHA5—spinal cord—abdominal aortic aneurysm	0.00288	0.00673	CbGeAlD
Crizotinib—PTK2B—kidney—abdominal aortic aneurysm	0.00287	0.0067	CbGeAlD
Crizotinib—EPHB4—connective tissue—abdominal aortic aneurysm	0.00282	0.00659	CbGeAlD
Crizotinib—JAK2—connective tissue—abdominal aortic aneurysm	0.0028	0.00655	CbGeAlD
Crizotinib—TEK—connective tissue—abdominal aortic aneurysm	0.0027	0.00631	CbGeAlD
Crizotinib—TBK1—kidney—abdominal aortic aneurysm	0.00264	0.00617	CbGeAlD
Crizotinib—PTK2—kidney—abdominal aortic aneurysm	0.00264	0.00617	CbGeAlD
Crizotinib—TYK2—kidney—abdominal aortic aneurysm	0.00262	0.00613	CbGeAlD
Crizotinib—TESK1—spinal cord—abdominal aortic aneurysm	0.00261	0.00608	CbGeAlD
Crizotinib—RPS6KB1—kidney—abdominal aortic aneurysm	0.00254	0.00593	CbGeAlD
Crizotinib—YES1—connective tissue—abdominal aortic aneurysm	0.0025	0.00583	CbGeAlD
Crizotinib—LIMK2—spinal cord—abdominal aortic aneurysm	0.00248	0.00579	CbGeAlD
Crizotinib—TAOK3—connective tissue—abdominal aortic aneurysm	0.00246	0.00575	CbGeAlD
Crizotinib—MAP3K12—spinal cord—abdominal aortic aneurysm	0.00245	0.00573	CbGeAlD
Crizotinib—ACVR1—spinal cord—abdominal aortic aneurysm	0.00245	0.00573	CbGeAlD
Crizotinib—EPHB4—kidney—abdominal aortic aneurysm	0.0024	0.00561	CbGeAlD
Crizotinib—SRC—connective tissue—abdominal aortic aneurysm	0.0024	0.00561	CbGeAlD
Crizotinib—JAK2—kidney—abdominal aortic aneurysm	0.00239	0.00557	CbGeAlD
Crizotinib—BMP2K—spinal cord—abdominal aortic aneurysm	0.00231	0.0054	CbGeAlD
Crizotinib—TEK—kidney—abdominal aortic aneurysm	0.0023	0.00537	CbGeAlD
Crizotinib—RIPK2—spinal cord—abdominal aortic aneurysm	0.00222	0.00517	CbGeAlD
Crizotinib—CSF1R—connective tissue—abdominal aortic aneurysm	0.00216	0.00503	CbGeAlD
Crizotinib—YES1—kidney—abdominal aortic aneurysm	0.00213	0.00496	CbGeAlD
Crizotinib—STK10—kidney—abdominal aortic aneurysm	0.00211	0.00492	CbGeAlD
Crizotinib—TAOK3—kidney—abdominal aortic aneurysm	0.0021	0.0049	CbGeAlD
Crizotinib—TBK1—spinal cord—abdominal aortic aneurysm	0.00206	0.0048	CbGeAlD
Crizotinib—PTK2—spinal cord—abdominal aortic aneurysm	0.00206	0.0048	CbGeAlD
Crizotinib—SRC—kidney—abdominal aortic aneurysm	0.00204	0.00477	CbGeAlD
Crizotinib—TYK2—spinal cord—abdominal aortic aneurysm	0.00204	0.00477	CbGeAlD
Crizotinib—RPS6KB1—spinal cord—abdominal aortic aneurysm	0.00198	0.00462	CbGeAlD
Crizotinib—AXL—spinal cord—abdominal aortic aneurysm	0.00196	0.00457	CbGeAlD
Crizotinib—SLK—spinal cord—abdominal aortic aneurysm	0.00189	0.0044	CbGeAlD
Crizotinib—CYP3A5—blood plasma—abdominal aortic aneurysm	0.00187	0.00437	CbGeAlD
Crizotinib—EPHB4—spinal cord—abdominal aortic aneurysm	0.00187	0.00437	CbGeAlD
Crizotinib—JAK2—spinal cord—abdominal aortic aneurysm	0.00186	0.00434	CbGeAlD
Crizotinib—TEK—spinal cord—abdominal aortic aneurysm	0.00179	0.00418	CbGeAlD
Crizotinib—MAP3K3—spinal cord—abdominal aortic aneurysm	0.00179	0.00418	CbGeAlD
Crizotinib—MAP4K5—spinal cord—abdominal aortic aneurysm	0.00179	0.00418	CbGeAlD
Crizotinib—EPHB6—spinal cord—abdominal aortic aneurysm	0.00171	0.004	CbGeAlD
Crizotinib—ABL1—connective tissue—abdominal aortic aneurysm	0.0017	0.00398	CbGeAlD
Crizotinib—YES1—spinal cord—abdominal aortic aneurysm	0.00165	0.00386	CbGeAlD
Crizotinib—TAOK3—spinal cord—abdominal aortic aneurysm	0.00163	0.00381	CbGeAlD
Crizotinib—SRC—spinal cord—abdominal aortic aneurysm	0.00159	0.00372	CbGeAlD
Crizotinib—ABL1—kidney—abdominal aortic aneurysm	0.00145	0.00339	CbGeAlD
Crizotinib—CSF1R—spinal cord—abdominal aortic aneurysm	0.00143	0.00334	CbGeAlD
Crizotinib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00141	0.00328	CbGeAlD
Crizotinib—ABL1—spinal cord—abdominal aortic aneurysm	0.00113	0.00264	CbGeAlD
Crizotinib—ABCB1—blood plasma—abdominal aortic aneurysm	0.000995	0.00232	CbGeAlD
Crizotinib—CYP3A5—kidney—abdominal aortic aneurysm	0.000849	0.00198	CbGeAlD
Crizotinib—CYP3A4—kidney—abdominal aortic aneurysm	0.000637	0.00149	CbGeAlD
Crizotinib—ABCB1—kidney—abdominal aortic aneurysm	0.000451	0.00105	CbGeAlD
Crizotinib—ABCB1—spinal cord—abdominal aortic aneurysm	0.000351	0.00082	CbGeAlD
Crizotinib—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	8.71e-05	0.000152	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—MMP9—abdominal aortic aneurysm	8.71e-05	0.000152	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NCF1—abdominal aortic aneurysm	8.7e-05	0.000152	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—NFKB1—abdominal aortic aneurysm	8.7e-05	0.000152	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—NFKB1—abdominal aortic aneurysm	8.7e-05	0.000152	CbGpPWpGaD
Crizotinib—CDK7—Disease—NOS2—abdominal aortic aneurysm	8.68e-05	0.000152	CbGpPWpGaD
Crizotinib—JAK2—Disease—NCF1—abdominal aortic aneurysm	8.67e-05	0.000152	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—MMP2—abdominal aortic aneurysm	8.64e-05	0.000151	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—NFKB1—abdominal aortic aneurysm	8.62e-05	0.000151	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—MMP2—abdominal aortic aneurysm	8.6e-05	0.00015	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—LDLR—abdominal aortic aneurysm	8.57e-05	0.00015	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—LRP1—abdominal aortic aneurysm	8.57e-05	0.00015	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—P2RY12—abdominal aortic aneurysm	8.56e-05	0.00015	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	8.52e-05	0.000149	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—MMP9—abdominal aortic aneurysm	8.51e-05	0.000149	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.47e-05	0.000148	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.47e-05	0.000148	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.38e-05	0.000147	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.38e-05	0.000147	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8.38e-05	0.000147	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—SERPINE1—abdominal aortic aneurysm	8.32e-05	0.000145	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	8.29e-05	0.000145	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—SERPINE1—abdominal aortic aneurysm	8.28e-05	0.000145	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	8.26e-05	0.000144	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	8.25e-05	0.000144	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	8.25e-05	0.000144	CbGpPWpGaD
Crizotinib—SRC—Disease—AAAS—abdominal aortic aneurysm	8.23e-05	0.000144	CbGpPWpGaD
Crizotinib—LCK—Immune System—NCF1—abdominal aortic aneurysm	8.23e-05	0.000144	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—NFKB1—abdominal aortic aneurysm	8.15e-05	0.000143	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.12e-05	0.000142	CbGpPWpGaD
Crizotinib—LCK—Disease—LDLR—abdominal aortic aneurysm	8.12e-05	0.000142	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—NOS2—abdominal aortic aneurysm	8.09e-05	0.000142	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—MMP2—abdominal aortic aneurysm	8.08e-05	0.000141	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP3—abdominal aortic aneurysm	8.05e-05	0.000141	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.03e-05	0.000141	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—MMP9—abdominal aortic aneurysm	8.02e-05	0.00014	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	8.01e-05	0.00014	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NCF1—abdominal aortic aneurysm	8.01e-05	0.00014	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.95e-05	0.000139	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.95e-05	0.000139	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—NFKB1—abdominal aortic aneurysm	7.93e-05	0.000139	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP3—abdominal aortic aneurysm	7.93e-05	0.000139	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—SERPINE1—abdominal aortic aneurysm	7.88e-05	0.000138	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—SERPINE1—abdominal aortic aneurysm	7.78e-05	0.000136	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—NFKB1—abdominal aortic aneurysm	7.72e-05	0.000135	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—AGT—abdominal aortic aneurysm	7.66e-05	0.000134	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—NFKB1—abdominal aortic aneurysm	7.61e-05	0.000133	CbGpPWpGaD
Crizotinib—LCK—Disease—NCF1—abdominal aortic aneurysm	7.6e-05	0.000133	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	7.59e-05	0.000133	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.58e-05	0.000133	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LRP1—abdominal aortic aneurysm	7.5e-05	0.000131	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.42e-05	0.00013	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP3—abdominal aortic aneurysm	7.36e-05	0.000129	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	7.36e-05	0.000129	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.35e-05	0.000129	CbGpPWpGaD
Crizotinib—CDK7—Disease—SERPINE1—abdominal aortic aneurysm	7.31e-05	0.000128	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	7.31e-05	0.000128	CbGpPWpGaD
Crizotinib—SRC—Immune System—NCF1—abdominal aortic aneurysm	7.28e-05	0.000127	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.27e-05	0.000127	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—NFKB1—abdominal aortic aneurysm	7.22e-05	0.000126	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—NFKB1—abdominal aortic aneurysm	7.22e-05	0.000126	CbGpPWpGaD
Crizotinib—SRC—Disease—LDLR—abdominal aortic aneurysm	7.19e-05	0.000126	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—NOS2—abdominal aortic aneurysm	7.17e-05	0.000125	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—AGT—abdominal aortic aneurysm	7.13e-05	0.000125	CbGpPWpGaD
Crizotinib—TBK1—Immune System—NFKB1—abdominal aortic aneurysm	7.1e-05	0.000124	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	7.09e-05	0.000124	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—P2RY12—abdominal aortic aneurysm	7.02e-05	0.000123	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—NFKB1—abdominal aortic aneurysm	7.01e-05	0.000123	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	6.99e-05	0.000122	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—APOE—abdominal aortic aneurysm	6.99e-05	0.000122	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—LDLR—abdominal aortic aneurysm	6.94e-05	0.000121	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—SERPINE1—abdominal aortic aneurysm	6.82e-05	0.000119	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—NFKB1—abdominal aortic aneurysm	6.81e-05	0.000119	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	6.8e-05	0.000119	CbGpPWpGaD
Crizotinib—SRC—Disease—NCF1—abdominal aortic aneurysm	6.72e-05	0.000118	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LRP1—abdominal aortic aneurysm	6.64e-05	0.000116	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	6.63e-05	0.000116	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—MMP9—abdominal aortic aneurysm	6.6e-05	0.000116	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—MMP9—abdominal aortic aneurysm	6.49e-05	0.000114	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—LDLR—abdominal aortic aneurysm	6.49e-05	0.000114	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NCF1—abdominal aortic aneurysm	6.49e-05	0.000114	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—MMP9—abdominal aortic aneurysm	6.46e-05	0.000113	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	6.43e-05	0.000113	CbGpPWpGaD
Crizotinib—JAK3—Immune System—NFKB1—abdominal aortic aneurysm	6.42e-05	0.000112	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—NFKB1—abdominal aortic aneurysm	6.42e-05	0.000112	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.42e-05	0.000112	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	6.4e-05	0.000112	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—NFKB1—abdominal aortic aneurysm	6.39e-05	0.000112	CbGpPWpGaD
Crizotinib—CDK7—Disease—PTGS2—abdominal aortic aneurysm	6.39e-05	0.000112	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—AGT—abdominal aortic aneurysm	6.35e-05	0.000111	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.35e-05	0.000111	CbGpPWpGaD
Crizotinib—TYK2—Disease—APOE—abdominal aortic aneurysm	6.33e-05	0.000111	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP3—abdominal aortic aneurysm	6.32e-05	0.00011	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	6.31e-05	0.00011	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MMP2—abdominal aortic aneurysm	6.27e-05	0.00011	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—AGT—abdominal aortic aneurysm	6.26e-05	0.00011	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP3—abdominal aortic aneurysm	6.23e-05	0.000109	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—APOE—abdominal aortic aneurysm	6.23e-05	0.000109	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—P2RY12—abdominal aortic aneurysm	6.21e-05	0.000109	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—APOE—abdominal aortic aneurysm	6.14e-05	0.000107	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—MMP9—abdominal aortic aneurysm	6.08e-05	0.000106	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NCF1—abdominal aortic aneurysm	6.07e-05	0.000106	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—SERPINE1—abdominal aortic aneurysm	6.03e-05	0.000106	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—NFKB1—abdominal aortic aneurysm	6.01e-05	0.000105	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—AGT—abdominal aortic aneurysm	5.99e-05	0.000105	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	5.91e-05	0.000103	CbGpPWpGaD
Crizotinib—TYK2—Disease—NOS2—abdominal aortic aneurysm	5.9e-05	0.000103	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	5.9e-05	0.000103	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—APOE—abdominal aortic aneurysm	5.87e-05	0.000103	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.87e-05	0.000103	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—AGT—abdominal aortic aneurysm	5.81e-05	0.000102	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—AGT—abdominal aortic aneurysm	5.81e-05	0.000102	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.81e-05	0.000102	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.75e-05	0.000101	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP3—abdominal aortic aneurysm	5.73e-05	0.0001	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—NFKB1—abdominal aortic aneurysm	5.73e-05	0.0001	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—APOE—abdominal aortic aneurysm	5.69e-05	9.96e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LDLR—abdominal aortic aneurysm	5.69e-05	9.95e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.68e-05	9.94e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—NFKB1—abdominal aortic aneurysm	5.67e-05	9.93e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—NFKB1—abdominal aortic aneurysm	5.65e-05	9.88e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—NFKB1—abdominal aortic aneurysm	5.64e-05	9.87e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.62e-05	9.84e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—NFKB1—abdominal aortic aneurysm	5.51e-05	9.64e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—NFKB1—abdominal aortic aneurysm	5.49e-05	9.6e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.48e-05	9.59e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	5.45e-05	9.53e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AAAS—abdominal aortic aneurysm	5.41e-05	9.46e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NCF1—abdominal aortic aneurysm	5.32e-05	9.3e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—NFKB1—abdominal aortic aneurysm	5.31e-05	9.29e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.23e-05	9.15e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AGTR1—abdominal aortic aneurysm	5.21e-05	9.12e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.16e-05	9.02e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LDLR—abdominal aortic aneurysm	5.03e-05	8.81e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—AGT—abdominal aortic aneurysm	4.99e-05	8.72e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—SERPINE1—abdominal aortic aneurysm	4.97e-05	8.7e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.94e-05	8.63e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—AGT—abdominal aortic aneurysm	4.92e-05	8.6e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—APOE—abdominal aortic aneurysm	4.89e-05	8.55e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.89e-05	8.55e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	4.88e-05	8.53e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—APOE—abdominal aortic aneurysm	4.82e-05	8.43e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.81e-05	8.42e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—APOE—abdominal aortic aneurysm	4.8e-05	8.4e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.79e-05	8.37e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	4.78e-05	8.37e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—LDLR—abdominal aortic aneurysm	4.72e-05	8.26e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MMP9—abdominal aortic aneurysm	4.71e-05	8.24e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NCF1—abdominal aortic aneurysm	4.71e-05	8.24e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—AGT—abdominal aortic aneurysm	4.66e-05	8.16e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—NFKB1—abdominal aortic aneurysm	4.66e-05	8.15e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—NFKB1—abdominal aortic aneurysm	4.65e-05	8.14e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP3—abdominal aortic aneurysm	4.64e-05	8.12e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.61e-05	8.06e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—APOE—abdominal aortic aneurysm	4.57e-05	7.99e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—AGT—abdominal aortic aneurysm	4.53e-05	7.92e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—NFKB1—abdominal aortic aneurysm	4.49e-05	7.86e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—NOS2—abdominal aortic aneurysm	4.47e-05	7.83e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.47e-05	7.82e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	4.47e-05	7.81e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—APOE—abdominal aortic aneurysm	4.44e-05	7.76e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—NFKB1—abdominal aortic aneurysm	4.43e-05	7.75e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP3—abdominal aortic aneurysm	4.35e-05	7.6e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—PTGS2—abdominal aortic aneurysm	4.34e-05	7.59e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AGTR1—abdominal aortic aneurysm	4.27e-05	7.47e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—APOE—abdominal aortic aneurysm	4.2e-05	7.36e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—NFKB1—abdominal aortic aneurysm	4.2e-05	7.35e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.2e-05	7.35e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.15e-05	7.27e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—NFKB1—abdominal aortic aneurysm	4.12e-05	7.2e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.11e-05	7.18e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—NFKB1—abdominal aortic aneurysm	4.08e-05	7.14e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	4.08e-05	7.14e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.05e-05	7.08e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	3.95e-05	6.92e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS2—abdominal aortic aneurysm	3.92e-05	6.86e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.84e-05	6.72e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.83e-05	6.71e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP3—abdominal aortic aneurysm	3.81e-05	6.66e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AGTR1—abdominal aortic aneurysm	3.78e-05	6.61e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.78e-05	6.61e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—SERPINE1—abdominal aortic aneurysm	3.77e-05	6.59e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.74e-05	6.55e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.73e-05	6.52e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—APOE—abdominal aortic aneurysm	3.72e-05	6.51e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.7e-05	6.48e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.69e-05	6.45e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AGT—abdominal aortic aneurysm	3.67e-05	6.41e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.65e-05	6.38e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APOE—abdominal aortic aneurysm	3.59e-05	6.28e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.59e-05	6.27e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	3.56e-05	6.23e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.53e-05	6.17e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.49e-05	6.11e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.48e-05	6.09e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS2—abdominal aortic aneurysm	3.47e-05	6.07e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AGT—abdominal aortic aneurysm	3.43e-05	6e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.42e-05	5.99e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.39e-05	5.92e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP3—abdominal aortic aneurysm	3.37e-05	5.9e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APOE—abdominal aortic aneurysm	3.36e-05	5.88e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—NFKB1—abdominal aortic aneurysm	3.3e-05	5.78e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—SERPINE1—abdominal aortic aneurysm	3.3e-05	5.77e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTGS2—abdominal aortic aneurysm	3.29e-05	5.75e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NFKB1—abdominal aortic aneurysm	3.29e-05	5.75e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NFKB1—abdominal aortic aneurysm	3.09e-05	5.41e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.02e-05	5.28e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AGT—abdominal aortic aneurysm	3.01e-05	5.26e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APOE—abdominal aortic aneurysm	2.94e-05	5.15e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.94e-05	5.14e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—SERPINE1—abdominal aortic aneurysm	2.92e-05	5.11e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.91e-05	5.08e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.9e-05	5.07e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—PTGS2—abdominal aortic aneurysm	2.88e-05	5.04e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.87e-05	5.01e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCL2—abdominal aortic aneurysm	2.83e-05	4.94e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.82e-05	4.93e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.75e-05	4.81e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.72e-05	4.75e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—NFKB1—abdominal aortic aneurysm	2.71e-05	4.74e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.67e-05	4.66e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AGT—abdominal aortic aneurysm	2.66e-05	4.65e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.64e-05	4.62e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.64e-05	4.62e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APOE—abdominal aortic aneurysm	2.61e-05	4.56e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—PTGS2—abdominal aortic aneurysm	2.55e-05	4.46e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	2.51e-05	4.4e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AGT—abdominal aortic aneurysm	2.49e-05	4.36e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL2—abdominal aortic aneurysm	2.48e-05	4.33e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOE—abdominal aortic aneurysm	2.44e-05	4.28e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—NFKB1—abdominal aortic aneurysm	2.4e-05	4.19e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.31e-05	4.04e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	2.19e-05	3.84e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL2—abdominal aortic aneurysm	2.19e-05	3.83e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.16e-05	3.78e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.14e-05	3.74e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.05e-05	3.58e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.02e-05	3.54e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2e-05	3.5e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	1.88e-05	3.29e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	1.84e-05	3.23e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—abdominal aortic aneurysm	1.77e-05	3.1e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.75e-05	3.06e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—abdominal aortic aneurysm	1.67e-05	2.93e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—abdominal aortic aneurysm	1.57e-05	2.74e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.55e-05	2.71e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	1.26e-05	2.21e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	1.16e-05	2.03e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	1.14e-05	1.99e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	7.79e-06	1.36e-05	CbGpPWpGaD
